Evelien Moorkens

Policies for biosimilar uptake in Europe: An overview

Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 346 citations · Full text

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape

Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys et al. · Frontiers in Pharmacology · 2017 · 105 citations · Full text

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 67 citations · Full text

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Yujeong Kim, Hye-Young Kwon, Brian Godman et al. · Frontiers in Pharmacology · 2020 · 55 citations · Full text

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting

Evelien Moorkens, Steven Simoens, Per Troein et al. · BioDrugs · 2019 · 33 citations · Full text